Cheryl Shuman Features a Vape Pen Filled With HempMedsPX CBD Hemp Oil
SAN DIEGO, Oct. 8, 2013 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to inform shareholders and the general public that HempMedsPX – a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc. – is increasing awareness of cannabidiol (CBD) rich hemp oil products.
HempMedsPX™ is proud to announce that Cheryl Shuman recently demonstrated a vape pen filled with HempMedsPX CBD hemp oil on the Fox News Geraldo at Large program. “Respected medical experts including Dr. Sanjay Gupta agree that vaporizing is a healthier intake method than smoking,” says Cheryl Shuman. Shuman continues, “The medical cannabis vaporizer market is expected to be $100 million this year in retail sales and more than $1 billion dollars for the electronic cigarette market.”
“Over the last 60 days we have received tremendous positive feedback at industry trade shows such from the Seattle High Times Cannabis Cup to the Boston Hempfest. Vaporizer pens are currently one of the fastest growing trends in our industry,” says Charles Vest, VP of Communications for HempMedsPX™. Vest continues, “Bringing a healthy aspect of including CBD in a vaporizing pen, rather than nicotine, sets us apart from the mainstream electronic cigarette market. This will provide visibility throughout non-dispensary outlets. We are honored that there is a rapidly growing global interest with our CBD and associated products and we look forward to featuring these products through mainstream news broadcasts and other media outlets.”
HempMedsPX™ has launched a multi-phased approach to increasing awareness of cannabidiol (CBD) rich hemp oil products including the newly launched Cibdex™ and Cibaderm™ lines. These innovative CBD products will be seen much more frequently in upcoming documentaries and in the news. The company was recently featured by top ranked Hispanic news broadcast Univision http://bit.ly/1hqgWpb
HempMedsPX™ represented the 2013 High Times Cannabis Cup award winner for Highest CBD Concentrate. These products can be purchased at http://www.HempMedsPX.com and http://RealScientificHempOil.com
HempMedsPX offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMedsPX is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the exclusive master distributor and contracted marketing company for CannaVest Corp. (OTC:CANV) and Medical Marijuana Inc. In addition to handling sales and distribution, HempMedsPX is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com
About CannaVest Corp.
CannaVest Corp. is in the business of investing and developing hemp-based cannabinoid companies. CannaVest Corp. also develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells—to third parties—raw product acquired by CannaVest Corp. pursuant to the company’s supply relationships in Europe. CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers.Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant, and CBD is derived from hemp stalk and seed. Additional information is available from OTCMarkets.com or by visiting CannaVest.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana, Inc., CannaVest Corp., and HempMedsPX do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell and distribute hemp-based products and are involved with Federally Legal Distribution of Medical Marijuana-based products within certain international markets.
For further information, please contact:
Investor relations contact:
Stuart T. Smith
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)